DIAMPA L XR 25+5+1000MG

DIAMPA L XR 25/5/1000MG Tablet is an advanced triple combination therapy for managing Type 2 Diabetes Mellitus. It combines Empagliflozin (25mg), Linagliptin (5mg), and Metformin (1000mg) to help lower blood glucose levels, improve insulin sensitivity, and promote better glycemic control in diabetic patients. This extended-release (XR) formulation ensures steady, long-lasting blood sugar control throughout the day.

Uses:

• Controls Type 2 Diabetes Mellitus

• Helps reduce blood sugar levels effectively

• Improves insulin sensitivity and glucose utilization

• Lowers risk of diabetic complications such as neuropathy and nephropathy

• Supports weight management and overall metabolic health

Benefits:

• Triple-action formula: Empagliflozin removes excess sugar via urine, Linagliptin enhances insulin secretion, and Metformin reduces liver glucose production

• Extended-release design: Provides consistent blood sugar control with fewer doses

• Heart and kidney protection: Empagliflozin helps reduce the risk of heart failure and renal damage

• Convenient once-daily dose improves patient compliance

• Promotes better energy levels and overall well-being

Possible Side Effects:

• Common: Nausea, diarrhea, increased urination, and mild dehydration

• Less common: Dizziness, urinary tract infection, genital infections, or low blood sugar (especially when combined with insulin)

• Rare: Allergic reactions or kidney-related issues (consult your physician if symptoms persist)

Precautions:

• Take with food to reduce stomach upset

• Monitor blood sugar levels regularly

• Stay hydrated and follow a balanced diabetic diet

• Avoid alcohol and inform your doctor of any kidney or liver problems before use